Jeremi Ongko
Jeremi Ongko
Verified email at
Cited by
Cited by
In-silico screening of inhibitor on protein epidermal growth factor receptor (EGFR)
J Ongko, JV Setiawan, AG Feronytha, A Juliana, A Effraim, M Wahjudi, ...
IOP conference series: earth and environmental science 1041 (1), 012075, 2022
Molecular docking of active compounds from traditional medicinal plants as ACE-2 protein (1R4L) inhibitor in searching for COVID-19 drug
E Tungary, J Ongko, J Sukweenadhi, Y Antonius
Research Journal of Pharmacy and Technology 15 (9), 4235-4240, 2022
Identification of potential activity of volatile compounds derived from pogostemon Cablin benth as antiviral of SARS-CoV-2
Y Antonius, J Ongko, PH Hardjo
International Journal of Applied Pharmaceutics (Int J App Pharm) 15 (1), 93-97, 2023
Identification of potential Ebola virus nucleoprotein (EBOV NP) inhibitor derivate from various traditional medicinal plants in Indonesia: in silico study
Y Antonius, J Ongko, J Sukweenadhi, SED Putra
Media Pharmaceutica Indonesiana 3 (4), 217-226, 2021
Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
P Silvia, J Ongko, Y Antonius
Journal of Pharmacy & Pharmacognosy Research 12 (5), 881-891, 2024
Epidermal growth factor receptor mutant inhibitors as NSCLC drugs
P Silvia, J Ongko, Y Antonius
The system can't perform the operation now. Try again later.
Articles 1–6